GSK buys COVID and flu vaccines from shrinking CureVac company
British drugmaker GSK on Wednesday bought out partner CureVac from its alliance to develop influenza vaccines and COVID-19, boosting its expertise in informatics RNA and expanding the German biotech company’s financial capabilities.
BELIEBTE BEITRÄGE
UK sets new climate target for 2035
November 13, 2024
Children go back to school after Valencia floods
November 13, 2024
Researchers document huge decline in African elephants
November 13, 2024
Mission: Impossible 8 title revealed
November 13, 2024
LIVEÜBERTRAGUNG